U.S. stocks ended Friday sharply higher as investors digested a batch of mixed economic data. Major indexes started October with gains but still booked weekly...
Money and investing stories popular with MarketWatch readers over the past week.
Read More...
Merck and Ridgeback Therapeutics Inc.'s promising oral antiviral could shift the direction of the pandemic by making it easier for people with COVID-19 to take...
Five9 Inc. will be going it alone now that the software company no longer plans to merge with Zoom Video Communications Inc., and analysts like the company's...
The Dow Jones rose as Merck surged on a new Covid pill. Disney gained on a Scarlett Johansson settlement. Joe Biden moved on infrastructure. Read More...
The cost of goods and services rose sharply again in August and left the rate of U.S. inflation at a 30-year high, with all signs pointing to price pressures...
A supplier of chipmaking equipment predicts a decade-long period of growing semiconductor production. Read More...
What better way to promote a new TV show than to scare the living daylights out of unsuspecting passersby? In a marketing stunt for Korean thriller “Squid...
While the U.S. House has failed to advance a $1 trillion bipartisan infrastructure bill, the long-awaited measure is likely to become reality eventually...
